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ABSTRACT. The objective of this article was to illustrate the MRI findings of uncommon
non-hepatocyte origin primary liver tumours, correlate them with the pathological
features and discuss differential diagnoses. In conclusion, the MRI findings of
uncommon benign and malignant non-hepatocyte-origin primary liver tumours vary.
Awareness of characteristic MRI features can aid differential diagnosis and prevent
unnecessary surgery.
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MRI has become an indispensable modality for the
evaluation of focal liver lesions. The absence of ionizing
radiation, unparalleled soft-tissue contrast and the
common use of liver-specific contrast agents are major
advantages over other imaging techniques. Two gadoli-
nium chelates — Gd-EOB-DTPA (gadolinium ethoxy-
benzyl diethylenetriaminepentaacectic acid; PrimovistH)
and Gd-BOPTA (gadobenate dimeglumine; MultihanceH)
— have the properties of both an extracellular agent and a
hepatobiliary agent, with the excretion into the biliary
system of 50% and 3–5%, respectively [1, 2].
In our institution, contrast-enhanced MRI was per-
formed using a breath-hold three-dimensional gradient-
echo sequence with fat saturation after an intravenous
bolus of 0.025mmol kg–1 Gd-EOB-DTPA and 0.1
mmol kg–1 Gd-BOPTA followed by a saline flush of
20 ml. The three-phase dynamic images were obtained at
30–35 s for arterial phase and 65–70 s for portal venous
phase and 5 min for equilibrium phase after the injection
of Gd-EOB-DTPA or Gd-BOPTA. Hepatobiliary phase
images were obtained 20 min after Gd-EOB-DTPA and
107–195 min (mean 138 min) after Gd-BOPTA injection.
Primary liver tumours may be classified into hepato-
cellular tumours, biliary tumours, mesenchymal tumours
and other tumours, according to the origin of cells. Some
hepatic tumours, especially uncommon tumours, can be
difficult to characterise, andMRI has been frequently used
to refine differential diagnoses to avoid unnecessary
surgery and correct inappropriate follow-up. In this
article, we will illustrate MRI findings of uncommon
benign and malignant non-hepatocyte origin primary
liver tumours, correlate them with pathological findings
and discuss their impact on differential diagnosis.
Biliary hepatic tumours
Primary hepatic neuroendocrine tumour
Just 55 cases of primary hepatic neuroendocrine tum-
our (NET) have been described in current literature [3].
Although the pathogenesis of primary hepatic NET has
not been established, one significant hypothesis suggests
that tumour cells might originate from the neuroendo-
crine cells in the epithelium of the intrahepatic bile duct
[4, 5]. These tumours are usually non-functioning neo-
plasms. Primary hepatic NET usually occurs as well-
demarcated solitary masses with internal fibrous septa
and capsule.
CT demonstrates a well-defined, low attenuated mass
with heterogeneous enhancement. MRI shows variable
high signal intensity on T2 weighted images depending on
the amount of fibrosis, calcification, haemorrhage and
necrosis, and relatively low signal intensity on T1 weighted
images compared with the liver parenchyma. On dynamic
contrast-enhanced study, early enhancement on arterial
phase and washout on portal venous phase are usually
seen. On equilibrium phase (5 min after the injec-
tion of the contrast), contrast accumulation in the centre
may be seen in those with a central scar (Figure 1) [6–8].
Bile duct adenoma (peribiliary gland hamartoma)
Bile duct adenoma (BDA) is a rare benign lesion of the
liver. Previously, BDA was considered a true neoplasm,
but recent reports suggest that BDA originates from
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peribiliary gland precursor tissue that has failed to
organise into a mature gland (a so-called peribiliary
gland hamartoma). BDA usually presents as a single
nodule measuring less than 2 cm in diameter located in
the subcapsular area of the liver [9]. Histologically, BDA
is a well-circumscribed, non-encapsulated nodule com-
posed of aggregates of bile ductules in the connective
tissue stroma with various degrees of chronic inflamma-
tion and collagenisation.
In contrast to biliary hamartoma, BDA is usually single,
does not show cystic changes and contains bile within the
ductules. Microscopically, fibrosis is denser in the centre
while bile ductules with abundant extracellular spaces are
denser in the periphery. There are very few reports on the
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Figure 1. A 54-year-old woman with primary hepatic neuroendocrine tumour. (a) T2 weighted MRI shows a primary lobulated
and hyperintense lesion with a small adjacent satellite nodule in the segment 4 of the liver. (b) On T1 weighted image, the mass
lesion shows hypointensity. (c) On arterial phase of gadolinium ethoxybenzyl diethylenetriaminepentaacectic acid (Gd-EOB-
DTPA) enhanced T1 weighted image, the mass lesions show the moderate enhancement. (d) On equilibrium phase, the mass
lesion shows defect with central enhancement. (e) Surgical specimen shows a protruded mass with fibrous capsule and central
scar at the posterior wall of the medial inferior area.
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radiological findings of BDA in the literature. In our case,
the BDA was hyperintense or isointense in the periphery,
and hypointense in the central area on emph>emph
type="inf">2 weighted MRI. In dynamic images, BDA
shows delayed and prolonged enhancement, especially in
the central portion on the equilibrium phase (Figure 2)
[10, 11].
Biliary hamartoma (Von Meyenberg complex)
Biliary hamartoma (BH), a ductal plate malformation,
consists of numerous small (usually ,0.5 cm), irregular-
shaped, dilated ductules embedded in a dense fibrous
stroma. The ductules are lined by cuboidal or flattened
epithelial cells and are not connected to the biliary system
[12]. On ultrasound, BH appear as numerous tiny
hyperechoic or hypoechoic foci that are scattered through-
out the liver. On CT, BH appear as small, low-attenuating
lesions with no enhancement. On MRI, BH are usually
seen as innumerable hyperintense nodules that do not
communicate with the biliary system (Figure 3). In one of
our cases, however, an unusual form of BH presented as a
single nodule. The nodule appeared hyperintense on T2
weighted images and hypointense on T1 weighted images
(Figure 4).
Non-epithelial tumours
Lymphangioepitheloima-like carcinoma
Lymphangioepitheloima-like carcinoma (LELC) is a
rare, undifferentiated carcinoma with intense lympho-
plasmacytoid stroma, originally described in the naso-
pharynx [13]. Primary LELC has been identified as the
variant type of cholangiocarcinoma. Although LELC
shows equivocal association with Epstein–Barr virus
(EBV) in diverse organs, EBV may play an important role
in the pathogenesis [14].
On ultrasound, LELC shows low echogenicity. CT scan
demonstrates low density without enhancement. To
date, the MRI appearances have not been reported. In
our case, the lobulated mass lesion appeared slightly
hyperintense on T2 weighted images and hypointense on
T1 weighted images. Contrast enhanced T1 weighted
(a)
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(b)
Figure 2. A 53-year-old man with a bile duct adenoma. (a) The axial T2 weighted image shows a three-layered, hyper-iso-
hypointense pattern from the periphery to the centre, round lesion at the subcapsular area of the liver. (b) On portal venous
phase of Gd-BOPTA-enhanced T1 weighted image, the mass shows thin hyperintense incomplete rim-like outer layer, thick
isointense middle layer and hypointense central area. (c) On equilibrium phase, the mass shows delayed and prolonged
enhancement, especially in the centre. (d) The surgical specimen shows a round, pinkish solid mass composed of aggregated bile
ductules with central denser fibrosis area.
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Figure 3. A 74-year-old man with biliary hamartomas. (a) On magnetic resonance cholangiopancreatography, numerous small
hyperintense foci are found in the liver. (b) Microscopic specimen (original magnification 6100; haemotoxylin and eosin stain)
shows an irregular gland with a low columnar epithelium in a fibrous stroma that is compatible with biliary hamartomas.
(a)
(c) (d)
(b)
Figure 4. A 53-year-old man with a solitary biliary hamartoma. (a) The T2 weighted image shows a hyperintense nodule. (b) On T1
weighted image, the mass shows heterogeneous hyperintensity. (c) On equilibrium phase of Gd-EOB-DTPA enhanced T1 weighted
image, the mass shows thin peripheral rim enhancement. (d) The microscopic specimen (original magnification6100; haemotoxylin
and eosin stain) shows irregular-shaped glandswith short columnar epithelium in fibrous stroma, compatiblewith a biliary hamartoma.
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MRI showed progressive enhancement in the periphery
of the lesion. On hepatobilliary phase, the lesion shows
hypointensity with a lobulated margin. However, the
imaging features on MRI of this entity will need to be
confirmed by future reports (Figure 5).
Schwannoma
Hepatic schwannoma is a very rare benign mesench-
ymal tumour that originates from a variety of hepatic
sympathetic and parasympathetic nerves distributed
among the intralobular connective tissues, portal vein
and hepatic arteries. This tumour is usually found along
the branches of the portal tracts [15, 16]. The histological
hallmarks of a schwannoma are a true capsule and a
mixture of Antoni A (hypercellular area) and Antoni B
(hypocellular area with a more myxoid matrix and water
content) regions. This tumour sometimes undergoes
secondary degeneration, resulting in cystic changes,
calcification deposits and haemorrhage formation [17].
On MRI, a schwannoma usually presents as an
encapsulated, well-demarcated round or ovoid mass.
The signal intensity on T1 and T2 weighted images varies
depending on the proportion of Antoni A and Antoni B
regions with the presence of secondary degeneration.
Schwannoma usually shows non-homogeneous high
signal intensity on T2 weighted images, low to inter-
mediate signal intensity on T1 weighted images and
variable enhancement on post-contrast images owing to
the mixture of Antoni A and B (Figure 6) [18].
Inflammatory pseudotumor
A hepatic inflammatory pseudotumour (IPT) is an
unusual lesion composed of proliferating fibrovascular
tissue infiltrated by inflammatory cells, and has the
(a)
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Figure 5. A 61-year-old man with lymphangioepithelioma-like carcinoma. (a) T2 weighted image shows a slightly hyperintense
nodular lesion in the segment 6 of the liver. (b) On arterial phase of Gd-EOB-DTPA enhanced T1 weighted image, minimal
enhancement is noted in the posterior aspect of lesion. (c) On equilibrium phase, the mass shows progressive enhancement in
the periphery of the lesion. (d) On hepatobilliary phase, the mass shows hypointense with a lobulated margin. (e) Surgical
specimen reveals a light yellow-coloured multinodular confluent type of mass, measuring 2.261.8 cm.
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Figure 6. A 29-year-old woman with a schwannoma. (a) The T2 weighted MRI shows a well-demarcated round heterogeneous,
hyperintense nodule. (b) The T1 weightedMRI shows a hypointense nodule. (c) No enhancement of themass is seen on portal venous
phase of Gd-EOB-DTPA enhanced T1 weighted MRI. (d) The microscopic specimen (original magnification6200; haemotoxylin and
eosin) of surgical specimen has storiform bundles of spindle cells arranged in whorls and surrounded by a fibrous capsule.
(a) (b)
(d)(c)
Figure 7. A 66-year-old woman with an inflammatory pseudotumour. (a) The T2 weighted image shows an ill-defined
hyperintense lobulated mass in the liver. (b and c) On arterial and equilibrium phases of Gd-BOPTA enhanced T1 weighted image,
the mass shows inhomogeneous gradual delayed enhancement (d) The microscopic specimen (6200; haemotoxylin and eosin
stain) of surgical specimen shows lymphocyte infiltration and fibroblastic proliferation of the surrounding connective tissue.
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potential for recurrence, persistent local growth and
spontaneous regression [19]. IPT can develop secondary
to recurrent cholangitis or portal vein infection, but the
pathogenesis is still unclear [19]. OnMRI, these lesions can
appear as solitary or multiple nodular lesions with hypo-
intensity or isointensity on T1 weighted images, isointen-
sity or slight hyperintensity on T2 weighted images and
variable enhancement on dynamic images owing to the
wide range of vascularity – from avascular to hypervas-
cular (Figure 7) [20]. Inaba et al [19] suggested that the
absence of enhancement on arterial phase may be the key
differential point of IPT from other hypervascular
tumours, such as hepatocellular carcinoma. However, it
is very difficult to differentiate these tumours from other
malignant tumours, especially cholangiocarcinoma, which
usually shows progressive enhancement [20].
Conclusions
MRI findings of uncommon non-hepatocyte benign and
malignant tumours in the liver vary, and can be either
specific or nonspecific. However, awareness of the
pathological and MRI findings of these tumours is
important not only for differential diagnosis from malig-
nant focal lesions, but also to avoid unnecessary treatment.
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